OIRA Conclusion of EO 12866 Regulatory Review

RIN: 0938-AS33         View EO 12866 Meetings Received Date: 08/31/2015 
Title: Medicare Clinical Diagnostic Laboratory Test Payment System (CMS-1621-P) 
Agency/Subagency: HHS / CMS   Stage: Proposed Rule 
Concluded Action: Consistent with Change  Concluded Date: 09/29/2015 
Legal Deadline: Statutory  Economically Significant: Yes 
Publication Date: 10/01/2015  Unfunded Mandates: No 
Major: Yes  Related To Homeland Security: No 
Regulatory Flexibility Analysis Required: Yes  Small Entities Affected: Businesses 
Federalism Implications: No  Affordable Care Act [Pub. L. 111-148 & 111-152]: Yes
International Impacts: No Dodd-Frank Wall Street Reform and Consumer Protection Act, [Pub. L. 111-203]: No
Pandemic Response: Uncollected